Cambridge Investment Research Advisors, Inc. Absci Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Absci Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 10,330 shares of ABSI stock, worth $32,952. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,330Holding current value
$32,952% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABSI
# of Institutions
141Shares Held
58.7MCall Options Held
180KPut Options Held
139K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.27MShares$26.4 Million0.19% of portfolio
-
Redmile Group, LLC San Francisco, CA8.25MShares$26.3 Million1.69% of portfolio
-
Fred Alger Management, LLC New York, NY6.51MShares$20.8 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.34MShares$17 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.77MShares$15.2 Million0.0% of portfolio
About Absci Corp
- Ticker ABSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 92,843,504
- Market Cap $296M
- Description
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....